- Cosmo Pharmaceuticals (CMOPF, Financial) expands its AI capabilities with EU MDR certification for Cerebro, an AI-powered guide for EGD procedures.
- Cerebro will be available through the AI Access platform integrated into Medtronic's GI Genius system.
- The system enhances upper GI tract procedures, complementing existing lower GI solutions.
Cosmo Pharmaceuticals (CMOPF) has achieved a significant milestone with the EU MDR certification of Cerebro, a real-time AI-powered guide designed for Esophagogastroduodenoscopy (EGD) procedures. This certification allows Cerebro to be distributed in the European market later this year through the AI Access platform, integrated with Medtronic's GI Genius intelligent endoscopy system. The integration ensures a robust distribution channel across Europe, enhancing procedural quality through advanced AI technology.
The Cerebro software utilizes deep learning algorithms to provide real-time analysis of endoscopic imaging, highlighting critical anatomical landmarks and identifying potential quality issues. It supports multiple imaging modalities, including White-Light, Narrow Band Imaging (NBI), Texture and Color Enhancement Imaging (TXI), and Blue Light Imaging (BLI). This innovative approach aims to standardize inspection protocols and generate comprehensive photo documentation, complete with coverage scores and procedural reports.
This advancement marks a strategic expansion of Cosmo's AI solutions to the upper gastrointestinal tract, complementing their existing successful applications in the lower GI procedures. The development of Cerebro has been in collaboration with the Faculty of Medicine at the Chinese University of Hong Kong, aiming to bridge the gap between technological innovation and clinical practice to enhance patient care.
Industry leaders such as Professor Philip Chiu from CUHK and Dr. Yuichi Mori from the University of Oslo have praised Cerebro's precision and its impact on improving patient outcomes. The AI-driven technology assists endoscopists in providing thorough examinations, ensuring comprehensive and accurate diagnosis without blind spots.
Saurabh Jejurikar, CEO of Endovision Limited, highlighted the achievement of the MDR certification as a testament to the team's innovative capabilities in developing cutting-edge AI solutions. The collaboration between Endovision and Cosmo underscores the commitment to advancing standardization through Computer-Aided Quality (CAQ) in endoscopy, setting a new benchmark in AI-driven healthcare solutions.